Published in Sci Rep on April 13, 2016
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (1990) 9.90
Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology (1997) 7.58
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut (2010) 6.34
Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21
Glycans in cancer and inflammation--potential for therapeutics and diagnostics. Nat Rev Drug Discov (2005) 6.14
Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03
Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA (2008) 5.94
Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer (2009) 5.31
Colorectal cancer in mice genetically deficient in the mucin Muc2. Science (2002) 5.08
Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med (2008) 4.83
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41
Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy (2008) 3.89
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
The interaction of wheat germ agglutinin with sialoglycoproteins. The role of sialic acid. J Biol Chem (1979) 3.40
Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep (2006) 2.82
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res (2001) 2.65
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res (1993) 2.39
In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology (2009) 2.33
AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.31
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17
Histochemistry of the surface mucous gel layer of the human colon. Gut (1997) 2.17
Lectins as molecules and as tools. Annu Rev Biochem (1986) 2.10
Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer (2015) 2.00
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res (1989) 1.93
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med (2012) 1.83
Molecular imaging in gastrointestinal endoscopy. Gastroenterology (2010) 1.79
The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol (2002) 1.46
Sessile serrated polyps at screening colonoscopy: have they been under diagnosed? Am J Gastroenterol (2014) 1.45
In vivo targeting of colonic dysplasia on fluorescence endoscopy with near-infrared octapeptide. Gut (2012) 1.17
Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins. Br J Nutr (1993) 1.09
Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer (1995) 1.06
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status. J Clin Pathol (2006) 1.05
Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer (1994) 1.04
Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Int J Cancer (1989) 1.00
Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut (1992) 0.94
Lectin binding to human colonocytes is predictive of colonic neoplasia. Am J Gastroenterol (1999) 0.90
Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases. Am J Pathol (1985) 0.89
Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study. Lancet (1999) 0.89
A scanning electron microscopy study of ultrastructural changes in the colonic mucosa of patients with large bowel tumours. Br J Surg (1981) 0.88
Traditional serrated adenomas (TSAs) admixed with other serrated (so-called precursor) polyps and conventional adenomas: a frequent occurrence. J Clin Pathol (2015) 0.85
Lectin soybean agglutinin: measurements in colonic epithelial cells of human subjects following supplemental dietary calcium. Cancer Lett (1991) 0.80
Colonic mucosa adjacent to adenomas and hyperplastic polyps--a morphological and histochemical study. Histopathology (1985) 0.77
Effects of fasting on serial measurements of hyperpolarized [1-(13) C]pyruvate metabolism in tumors. NMR Biomed (2016) 0.75
MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter. Nat Biotechnol (2016) 0.75
Predicting survival in patients with colorectal cancer. BMJ (2017) 0.75